皮肤小血管炎诊断检查建议:EADV血管炎工作组立场声明
欧洲皮肤病与性病学会(EADV)血管炎与血管病工作组组织国际专家,通过两轮Delphi问卷形成成人皮肤小血管炎(CSVV)诊断共识。共识强调诊断需结合临床表现、实验室检查和组织病理学,可触及性紫癜是多数SVV最可靠标志,怀疑免疫复合物血管炎时应从早期部分可褪色斑疹取Direct Immunofluorescence(DIF)活检。
要点
- 可触及性紫癜是多数小血管炎最可靠标志,提示免疫复合物血管炎。
- 怀疑免疫复合物血管炎时,应从早期部分可褪色斑疹取DIF活检。
- 诊断需结合临床表现、实验室检查和组织病理学,并按病情严重程度选择检查范围。
核心结论
- 专家组就成人CSVV管理达成高度共识,形成首个国际共识声明,并提出实用管理算法。
研究设计与样本
- 国际专家组成Delphi小组,通过两轮问卷收集数据,采用11点Likert量表衡量共识,每条陈述至少7票方为达成共识。
- 第一轮有20名专家参与,第二轮有17名专家参与。
主要发现
- 专家组一致认为CSVV诊断依赖临床表现、实验室检查和组织病理学的结合。
- 可触及性紫癜位于下肢时被视为多数SVV最可靠标志,也是免疫复合物血管炎的标志。
- 怀疑免疫复合物血管炎时,应从早期、部分可褪色的斑疹取皮肤活检行直接免疫荧光(DIF),因血管周围免疫球蛋白类型对进一步诊断重要。
- 常规HE活检的适当取材部位取决于皮损形态。
- 应进行完整病史采集和选择性实验室检查,以评估器官受累、潜在病因和相关疾病;诊断检查范围应基于SVV的严重程度、持续时间、全身症状和复发情况。
关键数值与推荐
- Delphi共识采用11点Likert量表(0=强烈不同意,10=强烈同意),每条陈述至少7票同意方为达成共识。
- Delphi评分3–7分的陈述在会议中讨论。
临床怎么用
- 临床怀疑CSVV时,应结合临床表现、实验室检查和组织病理学进行诊断。
- 发现下肢可触及性紫癜时,应警惕免疫复合物血管炎,并从早期部分可褪色斑疹取DIF活检。
- 根据皮损形态选择常规HE活检部位,并通过病史和选择性实验室检查评估器官受累及潜在病因。
- 诊断检查的范围应依据SVV的严重程度、持续时间、全身症状和复发情况决定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Small vessel vasculitides (SVV) comprise a heterogeneous group of cutaneous SVV (CSVV) that can be skin-limited or systemic. Given their diverse forms and symptoms and the lack of a standardized diagnostic approach, it is crucial to establish clear and consensus-driven recommendations for diagnosis. OBJECTIVES: To standardize diagnosis for the detection of the type, extent, potential causes or underlying conditions of CSVV. METHODS: International experts comprised the panel. The Delphi panel data was collected through two rounds of questionnaires. Agreement was measured using an 11-point Likert scale (0 = strongly disagree, 10 = strongly agree). A 7-vote minimum was required for agreement on each statement. Delphi panel statements scoring 3-7 were discussed during the meeting. RESULTS: 20 experts participated in the first round of the Delphi panel, while 17 experts took part in the second. They agreed that the diagnosis of CSVV relies on a combination of clinical manifestations, laboratory findings and histopathology. Palpable purpura on the lower extremities is recognized as the most reliable hallmark for most SVV and a sign of immune complex vasculitis. When the latter is suspected, a skin biopsy for direct immunofluorescence (DIF) should be obtained from an early, partially blanchable macule because the type of perivascular immunoglobulin is important for further diagnosis. The proper selection of biopsy sites for routine HE biopsy depends on the morphology of lesions. A comprehensive medical history and selected laboratory testing should be conducted to investigate organ involvement, potential causes and associated conditions. The extent of diagnostic procedures should be based on the severity, duration, systemic symptoms and recurrence of SVV. CONCLUSIONS: Experts reached a strong consensus on the management of CSVV patients, culminating in the first International Consensus Statement for adult CSVV. This statement proposes a practical management algorithm and underscores the importance of collaboration in rare diseases management.
引用
- Alpsoy E, Caproni M, Wetter DA, et al. Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force. J Eur Acad Dermatol Venereol. 2025. PMID: 41399325. doi:10.1111/jdv.70249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。